Elanco Animal Health (ELAN) Liabilities and Shareholders Equity (2017 - 2026)

Elanco Animal Health has disclosed Liabilities and Shareholders Equity across 10 years of filings, most recently posting $13.6 billion for Q2 2026.

• In Q2 2026, Liabilities and Shareholders Equity fell 1.32% year-over-year to $13.6 billion; the TTM figure through Jun 2026 stood at $53.7 billion (up 2.11% YoY), while the FY2025 annual figure was $13.4 billion, up 5.9% from the prior year.
• Liabilities and Shareholders Equity came in at $13.6 billion for Q2 2026 at Elanco Animal Health, up from $13.2 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $16.3 billion in Q1 2022 to a low of $12.6 billion in Q4 2024.
• Average Liabilities and Shareholders Equity over 5 years is $14.3 billion, with a median of $13.9 billion recorded in 2024.
• Year-over-year, Liabilities and Shareholders Equity fell 12.86% in 2024 and climbed 5.9% in 2025.
• Over 5 years, Liabilities and Shareholders Equity stood at $15.5 billion in 2022, then decreased by 7.29% to $14.4 billion in 2023, then declined by 12.17% to $12.6 billion in 2024, then gained by 5.9% to $13.4 billion in 2025, then advanced by 1.52% to $13.6 billion in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $13.6 billion in Q2 2026, $13.2 billion in Q1 2026, and $13.4 billion in Q4 2025.